Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by End-Users
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Increasing incidence of cancer
4.2.2. Rising awareness in emerging economies
4.3. Restraints:
4.3.1. Side-effects of treatment
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
7.3. Market Attractiveness Index, By Product Segment
7.3.1. Calcium Channel ?2-delta Ligands*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Antidepressants
7.3.3. Opioids
7.3.4. Others
8. By Application
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
8.3.1. Platinum Agents*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Taxanes
8.3.3. Vinca Alkaloids
8.3.4. Others
9. By End-Users
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users Segment
9.3. Market Attractiveness Index, By End-Users Segment
9.3.1. Hospitals & Clinics*
9.3.1.1. Introduction
9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3.2. Cancer Centers
10. By Region
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. The U.S.
10.4.6.2. Canada
10.4.6.3. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. Germany
10.5.6.2. The U.K.
10.5.6.3. France
10.5.6.4. Italy
10.5.6.5. Spain
10.5.6.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.6.1. Brazil
10.6.6.2. Argentina
10.6.6.3. Rest of South America
10.7. Asia Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.6.1. China
10.7.6.2. India
10.7.6.3. Japan
10.7.6.4. Australia
10.7.6.5. Rest of Asia Pacific
10.8. The Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Asahi Kasei Pharma Corp*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Regency Pharmaceuticals
12.3. MAKScientific LLC
12.4. Metys Pharmaceuticals AG
12.5. Nemus Bioscience Inc
12.6. PledPharma
12.7. Sova Pharmaceuticals Inc
12.8. DermaXon LLC
12.9. Immune Pharmaceuticals Inc.
12.10. Solasia Pharma K.K.
13. DataM Intelligence
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us